XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY (unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Redeemable Noncontrolling Interests
Class A and Class B Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Equity, including portion attributable to noncontrolling interest, beginning balance at Dec. 31, 2022 $ 2,414 $ 0 $ 0 $ 8,154 $ 3 $ (5,743) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 91         91  
Foreign currency translation adjustments, net of tax (19)       (19)    
Actuarial gain on defined severance benefits, net of tax 1       1    
Issuance of common stock upon exercise of stock options 3     3      
Issuance of common stock upon settlement of restricted stock units 0            
Equity-based compensation 70     70      
Equity, including portion attributable to noncontrolling interest, ending balance at Mar. 31, 2023 2,560 0 $ 0 8,227 (15) (5,652) 0
Beginning balance (in shares) at Dec. 31, 2022     1,773        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net issuance of common stock upon exercise of stock options (in shares)     1        
Issuance of common stock upon settlement of restricted stock units (in shares)     3        
Ending balance (in shares) at Mar. 31, 2023     1,777        
Equity, including portion attributable to noncontrolling interest, beginning balance at Dec. 31, 2022 2,414 0 $ 0 8,154 3 (5,743) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments, net of tax (27)            
Equity, including portion attributable to noncontrolling interest, ending balance at Jun. 30, 2023 2,775 0 $ 0 8,315 (33) (5,507) 0
Beginning balance (in shares) at Dec. 31, 2022     1,773        
Ending balance (in shares) at Jun. 30, 2023     1,781        
Equity, including portion attributable to noncontrolling interest, beginning balance at Mar. 31, 2023 2,560 0 $ 0 8,227 (15) (5,652) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 145         145  
Foreign currency translation adjustments, net of tax (8)       (8)    
Actuarial gain on defined severance benefits, net of tax (10)       (10)    
Issuance of common stock upon exercise of stock options 2     2      
Issuance of common stock upon settlement of restricted stock units 0            
Equity-based compensation 86     86      
Equity, including portion attributable to noncontrolling interest, ending balance at Jun. 30, 2023 2,775 0 $ 0 8,315 (33) (5,507) 0
Beginning balance (in shares) at Mar. 31, 2023     1,777        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net issuance of common stock upon exercise of stock options (in shares)     1        
Issuance of common stock upon settlement of restricted stock units (in shares)     3        
Ending balance (in shares) at Jun. 30, 2023     1,781        
Equity, including portion attributable to noncontrolling interest, beginning balance at Dec. 31, 2023 4,089 15 $ 0 8,489 (17) (4,383) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 1 (25)       5 (4)
Capital contributions from noncontrolling interest holders 0 55          
Recognition of noncontrolling interest upon acquisition 10 69         10
Foreign currency translation adjustments, net of tax (105)       (105)    
Actuarial gain on defined severance benefits, net of tax 1       1    
Issuance of common stock upon exercise of stock options 1     1      
Issuance of common stock upon settlement of restricted stock units 0            
Equity-based compensation 88     88      
Equity, including portion attributable to noncontrolling interest, ending balance at Mar. 31, 2024 4,085 114 $ 0 8,578 (121) (4,378) 6
Beginning balance (in shares) at Dec. 31, 2023     1,791        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon settlement of restricted stock units (in shares)     4        
Ending balance (in shares) at Mar. 31, 2024     1,795        
Equity, including portion attributable to noncontrolling interest, beginning balance at Dec. 31, 2023 4,089 15 $ 0 8,489 (17) (4,383) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments, net of tax (184)            
Equity, including portion attributable to noncontrolling interest, ending balance at Jun. 30, 2024 3,855 92 $ 0 8,509 (198) (4,455) (1)
Beginning balance (in shares) at Dec. 31, 2023     1,791        
Ending balance (in shares) at Jun. 30, 2024     1,790        
Equity, including portion attributable to noncontrolling interest, beginning balance at Mar. 31, 2024 4,085 114 $ 0 8,578 (121) (4,378) 6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (84) (21)       (77) (7)
Foreign currency translation adjustments, net of tax (79) (1)     (79)    
Actuarial gain on defined severance benefits, net of tax 2       2    
Issuance of common stock upon exercise of stock options 0            
Issuance of common stock upon settlement of restricted stock units 0            
Repurchase of Class A common stock (178)     (178)      
Equity-based compensation 109     109      
Equity, including portion attributable to noncontrolling interest, ending balance at Jun. 30, 2024 $ 3,855 $ 92 $ 0 $ 8,509 $ (198) $ (4,455) $ (1)
Beginning balance (in shares) at Mar. 31, 2024     1,795        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net issuance of common stock upon exercise of stock options (in shares)     1        
Issuance of common stock upon settlement of restricted stock units (in shares)     4        
Stock repurchased during period (in shares)     (10)        
Ending balance (in shares) at Jun. 30, 2024     1,790